Smart Hyaluronic Acid-Based Dermal Fillers

Next-generation hyaluronic acid-based dermal fillers with integrated sensors, machine learning algorithms, and advanced biomaterials for real-time monitoring, personalized treatment, and enhanced biocompatibility.

The original patent disclosed methods for preparing modified hyaluronate compositions for soft tissue fillers, but these compositions lack real-time monitoring capabilities, personalized treatment options, and advanced biomaterials. The new inventive concept addresses these limitations by integrating sensors, machine learning algorithms, and advanced biomaterials to create smart hyaluronic acid-based dermal fillers.

The new inventive concept comprises a system for real-time monitoring of hyaluronic acid-based dermal fillers, wherein a sensor integrated into the filler composition tracks changes in particle size, hydration levels, and molecular weight distribution in response to environmental stimuli. Additionally, machine learning algorithms are used to generate personalized, adaptive hyaluronic acid-based dermal fillers based on individual patient characteristics. The fillers may incorporate graphene oxide nanoparticles to enhance biocompatibility, mechanical strength, and thermal stability. A biohybrid dermal filler system may also be employed, comprising a hyaluronic acid-based matrix integrated with living cells to promote tissue regeneration and remodeling. Furthermore, a modular, multi-layered hyaluronic acid-based dermal filler device may be used, comprising interchangeable layers with tailored properties to address diverse aesthetic and therapeutic needs.

The new inventive concept is novel and non-obvious in its integration of sensors, machine learning algorithms, and advanced biomaterials into hyaluronic acid-based dermal fillers, which enables real-time monitoring, personalized treatment, and enhanced biocompatibility. The use of graphene oxide nanoparticles, biohybrid systems, and modular devices are also new and non-obvious features.

Alternative embodiments of the inventive concept may include the use of different types of sensors, machine learning algorithms, or biomaterials. Variations may also include the development of implantable devices or injectable formulations with integrated sensors and biomaterials.

The new inventive concept has significant commercial potential in the cosmetic and pharmaceutical industries, particularly in the fields of dermatology and aesthetic medicine. The smart hyaluronic acid-based dermal fillers may be used for a wide range of applications, including facial rejuvenation, skin revitalization, and scar treatment.